Reference
FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product Internet Document : 8 Aug 2023. Available from: URL: https://www.fda.gov/news-events/press-announcements/fda-approves-second-over-counter-naloxone-nasal-spray-product
Rights and permissions
About this article
Cite this article
FDA approves RiVive naloxone nasal spray for opioid overdose. Reactions Weekly 1969, 2 (2023). https://doi.org/10.1007/s40278-023-44468-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-44468-9